More reported that they had stopped taking the drugs due to difficulty affording them (14%) than reported they had stopped due to side effects (13%)
Currently, only 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
Additionally, Peak doesnt offer brand-name medications or non-injectable formats
No study has asked the broader question: do GLP-1s work against substance use disorders across the board, and can they reduce the serious harms of addiction, including overdose and drug-related death
Hanikoglu A et al
Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR